Search Within

Bernard Bochner

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (80)
  2. Journal Article (43)
  3. Correspondence (2)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. Human Oncology and Pathogenesis Program (127)
  2. Surgery (127)
  3. Urology (127)
  4. Department of Medicine (124)
  5. Genitourinary Oncology Service (124)
  6. Solid Tumor Oncology Division (124)

More Groups

People
  1. David Solit (120)
  2. Hikmat Al-Ahmadie (117)
  3. Gopakumar Iyer (113)
  4. Dean Bajorin (95)
  5. Jonathan Rosenberg (86)
  6. Michael Berger (69)

More People

Years
  1. 2025 (2)
  2. 2024 (10)
  3. 2023 (10)
  4. 2022 (10)
  5. 2021 (10)
  6. 2020 (7)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. Laboratory Investigation (19)
  3. Modern Pathology (17)
  4. Clinical Cancer Research (8)
  5. Urologic Oncology: Seminars and Original Investigations (8)
  6. Cancer Research (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (33)
  2. Nature Publishing Group (25)
  3. American Association for Cancer Research (17)
  4. Nature Research (17)
  5. Elsevier Inc. (12)
  6. Elsevier Science, Inc. (10)

More Publishers

Results (127)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updated long-term follow-up from a phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Jayalath, V.; Teo, M. Y.; Assel, M.; Rodriguez, D.; Meyerson, A.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Transcriptional analysis of bladder cancer histologic subtypes reveals novel drug target heterogeneity
    Meeting Abstract

    Tallman, J. E.; Kuo, F.; Koll, F.; Alam, S. M.; Basar, M.; Luo, J.; Gao, S. P.; Tang, X.; Yol, C.; Gokturk, G.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Molecular, immunohistochemical and clinical determinants of urothelial carcinoma of the bladder with nested subtype
    Meeting Abstract

    Koll, F. J.; Basar, M.; Chen, Z.; Tin, A. L.; Alam, S. M.; Tallman, J. E.; Clinton, T. N.; Whiting, K.; Chen, J. F.; Sarungbam, J.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Differential NEUROD1, ASCL1, and POU2F3 expression defines molecular subsets of bladder small cell/neuroendocrine carcinoma with prognostic implications
    Journal Article

    Akbulut, D.; Whiting, K.; Teo, M. Y.; Tallman, J. E.; Ozcan, G. G.; Basar, M.; Jia, L.; Rammal, R.; Chen, J. F.; Sarungbam, J.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • ERBB2 alterations in non-muscle invasive bladder cancer are associated with a distinct genomic signature
    Meeting Abstract

    Alam, S. M.; Tallman, J.; Koll, F.; D'Souza, N.; de Jesus Escano, M.; Donahue, T.; Goh, A.; Sarungbam, J.; Berger, M.; Schultz, N.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Genomic characterization of high-grade Ta urothelial carcinoma with and without carcinoma in situ
    Meeting Abstract

    Tallman, J. E.; Alam, S. M.; Koll, F.; Baky, F. J.; D'Souza, N.; de Jesus Escano, M.; Donahue, T. F.; Goh, A. C.; Sarungbam, J.; Berger, M. F.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Clinical, molecular and immunohistochemical profiles of clear cell adenocarcinoma of the urinary tract
    Meeting Abstract

    Koll, F.; Rammal, R.; Chen, Z.; Basar, M.; Alam, S. M.; Tallman, J. E.; Pietzak, E.; Dalbagni, G.; Donahue, T.; Donat, S. M.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Carcinoma in situ and urinary cytology as an indicator of minimal residual disease in patients with non-muscle invasive bladder cancer treated with BCG
    Meeting Abstract

    Katims, A. B.; D'Souza, N.; De Jesus Escaño, M. R.; Gokturk, G.; Basar, M.; Solit, D. B.; Iyer, G.; Bochner, B. H.; Goh, A.; Donahue, T. A.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Comutational patterns in FGFR3-altered non-muscle invasive bladder cancer influence recurrence and progression
    Meeting Abstract

    D'Souza, N.; de Jesus Escano, M.; Alam, S. M.; Gao, S.; Tang, X.; Goh, A.; Bochner, B. H.; Solit, D.; Iyer, G.; Al-Ahmadie, H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save